Tuesday - January 20, 2026

All the Presidents’ Dates Brings American History to Life – One Date at a Time

A uniquely engaging reference that transforms presidential history into an accessible, date-driven journey. By organizing key moments, births, marriages, terms in office, and pivotal milestones. All the Presidents’ Dates reveals patterns and connections across administrations, inviting readers to discover American … Continue reading

Parkinson’s Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Parkinson’s Disease pipeline constitutes 80+ key companies continuously working towards developing 100+ Parkinson’s Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Hearing Loss Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Sensorion, Fennec Pharma, Sound Pharma, Decibel Therapeutics, Akouos

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hearing Loss pipeline constitutes 30+ key companies continuously working towards developing 35+ Hearing Loss treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Sickle Cell Disease Market Reaches USD 650 Million in 2023, Gene Therapies and Novel Pipelines Set to Transform Growth Through 2034, estimates DelveInsight

Sickle Cell Disease Market Sickle Cell Disease market players active in the domain include Cellectis, Sana Biotechnology, Global Blood Therapeutics, CSL Behring, Pfizer, Aruvant Sciences, Graphite Bio, Novartis, Agios Pharmaceuticals, Forma Therapeutics, Vertex Pharmaceuticals, Alfasigma, Novo Nordisk, bluebird bio, ExCellThera, … Continue reading

Waldenstrom Macroglobulinemia Market Set for Steady Growth Through 2034, Driven by Emerging Therapies and Rising Diagnosis Rates, estimates DelveInsight

Waldenstrom Macroglobulinemia Market Waldenstrom Macroglobulinemia companies include AbbVie, Cellectar Biosciences, TG Therapeutics, Eli Lilly, Celgene, AstraZeneca, ADC Therapeutics, Amgen, Merck, Onyx Therapeutics, BeiGene, GSK, InnoCare Pharma, Millennium Pharma, Janssen, among others. Waldenström macroglobulinemia (WM) is a rare, indolent form of … Continue reading

Hutchinson-Gilford Progeria Syndrome (HGPS) Market Analysis 2032: Pipeline Innovation and Orphan Drug Focus Drive Future Expansion, says DelveInsight

Hutchinson-Gilford Progeria Syndrome (HGPS) Market Hutchinson-Gilford Progeria Syndrome Companies include Eiger BioPharmaceuticals, Inc., The Progeria Research Foundation, Ionis Pharmaceuticals, Inc., Merck & Co., Inc., Ultragenyx Pharmaceutical Inc., BioMarin Pharmaceutical Inc., Sangamo Therapeutics, Inc., BridgeBio Pharma, Inc., REGENXBIO Inc., Vertex Pharmaceuticals … Continue reading

Hereditary Angioedema Market Poised for Strong Growth, Valued at ~USD 3 Billion in 2023 and Set to Expand Through 2034: DelveInsight

Hereditary Angioedema Market Key companies active in the Hereditary Angioedema space include Ionis Pharmaceuticals, Astria Therapeutics, KalVista Pharmaceuticals, Intellia Therapeutics, BioMarin Pharmaceutical, CSL Behring, Pharvaris Netherlands B.V., Takeda, Shire, and several other industry participants. The Hereditary Angioedema (HAE) market was … Continue reading

Advanced Melanoma Pipeline Expands With 60+ Investigational Therapies and 55+ Active Developers, Reports DelveInsight

Advanced Melanoma Pipeline Advanced Melanoma companies include Replimune, IO Biotech, BioNTech SE, Perspective Therapeutics, Agenus Inc., Dragonfly Therapeutics, Iovance Biotherapeutics, Novartis, AstraZeneca, Exelixis, Immunocore, BeiGene, Biocad, Merck Sharp & Dohme, Genentech, Amgen, and others. DelveInsight’s Advanced Melanoma Pipeline Insightpresents a … Continue reading